Return to search

AbCellera nabs Series B led by OrbiMed and DCVC Bio

Vancouver, British Columbia-based AbCellera, a biotech company, has raised US$105 million in Series B financing.

Vancouver, British Columbia-based AbCellera, a biotech company, has raised US$105 million in Series B financing. OrbiMed and DCVC Bio led the round.

Source: Press Release